Northwest Biotherapeutics, Inc.
NWBO
$0.17
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 595.00K | 1.79M | 3.04M | 4.56M | 4.32M |
| Total Receivables | -- | -- | 311.00K | 311.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.98M | 4.42M | 2.17M | 2.33M | 1.84M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.57M | 6.20M | 5.52M | 7.20M | 6.16M |
|
|
|||||
| Total Current Assets | 2.57M | 6.20M | 5.52M | 7.20M | 6.16M |
| Net Property, Plant & Equipment | 20.46M | 20.82M | 21.60M | 21.14M | 21.10M |
| Long-term Investments | 626.00K | 626.00K | 626.00K | 626.00K | 626.00K |
| Goodwill | 626.00K | 626.00K | 626.00K | 626.00K | 626.00K |
| Total Other Intangibles | 51.93M | 52.05M | 53.19M | 1.29M | 1.29M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 354.00K | 354.00K | 356.00K | 358.00K | 370.00K |
| Total Assets | 75.94M | 80.05M | 81.29M | 30.61M | 29.55M |
|
|
|||||
| Total Accounts Payable | 32.53M | 31.58M | 30.82M | 26.88M | 23.66M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 10.25M | 11.65M | 9.47M | 13.57M | 16.31M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 23.49M | 31.84M | 33.07M | 27.23M | 25.93M |
| Total Finance Division Other Current Liabilities | 7.09M | 7.90M | 18.35M | 20.24M | 18.02M |
| Total Other Current Liabilities | 7.09M | 7.90M | 18.35M | 20.24M | 18.02M |
| Total Current Liabilities | 73.35M | 82.97M | 91.70M | 87.91M | 83.92M |
|
|
|||||
| Total Current Liabilities | 73.35M | 82.97M | 91.70M | 87.91M | 83.92M |
| Long-Term Debt | 18.45M | 16.21M | 17.88M | 31.81M | 22.94M |
| Short-term Debt | 10.25M | 11.65M | 9.47M | 13.57M | 16.31M |
| Capital Leases | 4.26M | 4.29M | 4.41M | 4.45M | 4.62M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 14.66M | 14.64M | 14.87M | 1.70M | 4.70M |
| Total Liabilities | 110.72M | 118.11M | 128.86M | 125.86M | 116.18M |
|
|
|||||
| Common Stock & APIC | 1.47B | 1.46B | 1.44B | 1.40B | 1.38B |
| Retained Earnings | -1.52B | -1.51B | -1.50B | -1.51B | -1.48B |
| Treasury Stock & Other | -337.00K | -520.00K | -1.02M | -1.30M | -1.93M |
| Total Common Equity | -45.17M | -50.54M | -60.28M | -108.65M | -100.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 10.40M | 12.48M | 12.71M | 13.40M | 13.75M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 10.40M | 12.48M | 12.71M | 13.40M | 13.75M |
|
|
|||||
| Total Common Equity | -45.17M | -50.54M | -60.28M | -108.65M | -100.39M |
| Total Preferred Equity | 10.40M | 12.48M | 12.71M | 13.40M | 13.75M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -34.78M | -38.06M | -47.57M | -95.25M | -86.64M |
|
|
|||||